XRTX
Xyratex Ltd.
NASDAQ · Healthcare · Biotechnology · CA
$1.01
−18.55%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-68.2%
Return on equity
-60.7%
Return on assets
-71.4%
Return on invested capital
0.00x
Asset turnover
-$5.0M
Cash from operations
$0.55
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026